Advertising
Supported by
On the eve of the Republican convention, President Trump cited the approval as news, but critics see political motivations.
Right now
New Zealand Prime Minister Jacinda Ardern has prolonged a closure in Auckland to involve an increasing number of cases.
Transcription
“Today I am pleased to make a historical announcement indeed in our fight against the ‘Chinese virus’ that will save countless lives: the FDA issued an emergency use authorization, and it is such a harsh term “emergency use authorization” for a remedy called convalescence plasma. It is a harsh cure that transfuses very, very strong antibodies from the blood of recovered patients to help treat patients fighting an existing infection. At an incredible rate of good luck. Today’s action will greatly expand access to this remedy. »
On Sunday, the Food and Drug Administration (FDA) granted emergency approval for increased use of antibody-rich blood plasma to hospitalized coronavirus patients, allowing President Trump, who emphasized that the firm will act more temporarily to combat the pandemic, demanding progress on the eve of the Republican convention.
Trump cited the pass, which had been blocked by considerations by more sensible government scientists about their knowledge, as clever news in the fight against a disease that has claimed 176,000 deaths in the United States and left the country much further. effectiveness of their response.
At a press conference, he described the remedy as “a hard therapy” that became imaginable “mobilizing all the powers of the federal government.”
The resolution will expand the use of a remedy that has already been administered to more than 70,000 patients. But the F.D.A. benefits cited only for some patients. And, unlike a new drug, plasma cannot be manufactured in millions of doses; availability is limited through blood donations. Trump suggested that everyone who has recovered from the virus donate plasma, saying there is a national crusade to collect it.
Trump has described his calls to reduce bureaucracy and speed up the approval of remedies and vaccines as a reaction to a public fitness emergency.
But Sunday’s announcement came a day after repeating his unfounded statement that the F.D.A. intentionally delayed in decision-making until after the election, this time posing a “deep state.” The indictment has exacerbated considerations among some government scientists, outdoor experts, and democrats that the president’s political desires can undermine the integrity of the regulatory process, undermine public confidence in security, and introduce some other form of public fitness risk.
No randomized trial of the type that researchers are the most physically powerful has yet demonstrated the advantages of convalescent plasma. But the F.D.A. He said knowledge so far, adding more than a dozen published studies, showed that it is “moderate to believe” that the remedy “may be effective in reducing severity or shortening the duration of Covid-19 disease in some cases. hospitalized patients, “especially those who get it early.
White House officials have called for immediate approval not only of Covid-19 treatments, but also of vaccines. His public statements that an effective vaccine could be imminent have alarmed scientists who are concerned that the Tension of the White House may result in scheduled premature approval to increase the president’s chances of re-election.
In a July 30 meeting with President Nancy Pelosi and Senator Chuck Schumer of New York, the leader of the Democratic minority, senior management officials warned that emergency approval of a vaccine can be granted before phase 3 trials in the United States are completed, in all cases. probability as early as September, according to two other people informed about the discussion. Such a resolution would be very important and would probably raise further considerations as to whether management was putting pressure on the F.D.A. pass drugs for political purposes.
Senior management officials disputed the minutes of the meeting, saying that Mark Meadows, the White House staff leader, and Treasury Secretary Steven Mnuchin were misrepresented or misinterpreted on each and every major issue.
In Russia, President Vladimir V. Putin announced this month that a billion doses of a vaccine opposed to the new coronavirus would soon be deployed, but Russian fitness officials were on the defensive because the vaccine was not tested at a complex, randomized giant controlled stage. Trials.
By skipping such tests, Russia is potentially putting other people in danger to earn propaganda points, fitness experts warn.
An updated list of possible solutions for Covid-19.
Global summary
When European countries ordered corporations to close and staff to stay at home while the coronavirus spread, governments took competitive measures for staff in the face of massive unemployment, extending billions to businesses for others to continue working.
Layoffs come anyway.
A tsunami of task cuts is about to strike Europe as corporations prepare to put in place radical reduction plans to compensate for the collapse of their businesses. Government-backed licensing programmes, which have helped ensure the monetary security of approximately one-third of the European workforce, are expected to end in the coming months.
According to a through McKinsey and Company, up to 59 million jobs are at risk of reduced hours or wages, transitional leave or permanent layoffs, particularly in sectors such as transportation and retail.
Governments warn that millions of others will soon lose their paychecks, and the European Central Bank said last week that unemployment is likely to remain higher even if the pandemic resumes.
“Europe has managed to mitigate the initial effects of the crisis,” said John Hurley, director of studies at Eurofound, the European Union’s study arm. “But in all likelihood, unemployment will come from one point to another, especially when beneficiary licensing systems begin to decline.
“There’s going to be a jolt, ” he added, “and it’s going to be pretty ugly.”
Compared to the United States, which lost more than 20 million jobs in April alone, permit systems in the European Union prevented unemployment from breaking the charts. Britain, Denmark, France and Germany are among the countries that have used partial unemployment schemes, de facto nationalizing the paychecks of some 60 million employees in the sector.
But even before a recent increase in coronavirus cases, the economic damage of the pandemic was increasing, and it now appears that these costly government systems have delayed, rather than prevented, the pain of some workers. For some corporations, disruption is the most productive time to move forward with a long-planned staff reduction.
Airbus, BP, Renault, Lufthansa, Air France, Branch Chain Debenhams, Bank of Ireland, W.H. Store. Smith and even McLaren Group, which includes the Formula One racing team, as well as countless small businesses, are among the planned cuts that will take factory staff, retail staff and well-paid administrative staff to the unemployed ranks.
In advances around the world:
Prime Minister Jacinda Ardern on Monday extended a blockade in Auckland, New Zealand’s largest city, until Sunday night. Restrictions were due to expire on Wednesday, but Ardern said additional time was needed to ensure that a group of viruses in Auckland was under control. Eight new cases related to the cluster, demonstrated or likely, were announced on Monday, bringing the total to 101. The prime minister also claimed that masks are now mandatory on public transport across the country.
The first volunteer inoculated on Monday with a “made in Italy” vaccine at the Spallanzani Hospital in Rome, which specializes in infectious diseases. The vaccine is produced through ReiThera, a biotechnology company founded near Rome but based in Switzerland. Francesco Vaia, medical director of Spallanzani, said that if all went well, the vaccine would be produced next spring.
Advertising